2026年全球神經調控市場報告

近年來，神經調控市場發展迅速，預計將從2025年的76.2億美元成長到2026年的84.5億美元，複合年成長率達10.9%。過去幾年的成長可歸因於多種因素，例如慢性疼痛疾病盛行率的上升、神經系統疾病發生率的增加、微創療法的接受度不斷提高、專業疼痛管理中心的擴張以及先進植入式醫療設備的廣泛應用。

預計未來幾年神經調控市場將快速成長，到2030年市場規模將達到128.8億美元，複合年成長率（CAGR）為11.1%。預測期內的成長要素包括：人工智慧輔助神經調控系統的日益普及、家庭神經調控療法需求的成長、精神和神經系統疾病適應症的擴大、對患者個體化刺激通訊協定的日益重視，以及生物材料技術和設備小型化的持續進步。預測期內的主要趨勢包括：植入式神經調控設備的日益普及、非侵入性神經調控療法的廣泛應用、智慧可程式設計刺激器的日益整合、神經調控應用領域從疼痛治療擴展到其他領域，以及對個人化神經療法的日益關注。

預計未來幾年，醫療費用支出的成長將推動神經調控市場的發展。醫療費用支出是指分配給醫療保健及相關活動的總資金，包括醫療服務提供、公共和私人醫療保險、健康研究以及公共衛生項目。支出的成長將支持神經系統疾病新治療方法和診斷方法的開發和應用，並為創新神經調控技術的研究和開發提供額外資金，從而提高其療效、安全性和標靶化能力。例如，根據美國醫療保險和醫療補助服務中心（CMS）的數據，截至2025年6月，美國醫療費用支出將成長7.5%，到2023年達到4.9兆美元（人均14,570美元），相當於美國國內生產總值（GDP）的17.6%。因此，醫療費用支出的成長正在推動神經調控市場的發展。

神經調控領域的主要企業正優先研發下一代解決方案，以提高治療精準度、改善病患舒適度並增強自身競爭力。這些解決方案包括先進的植入式脈衝產生器（IPG）。 IPG 是一種小型電池供電設備，通常皮下植入胸部或腹部，用於輸送可控電刺激以治療神經系統疾病。持續的技術創新致力於實現更個人化的治療、延長電池壽命並簡化植入手術。例如，2023 年 7 月，波士頓科學公司（Boston Scientific）的 Vercise Neural Navigator 5 軟體及其搭載的 STIMVIEW XT 技術獲得美國食品藥物管理局（FDA）核准，可與第四代 Vercise Genus 深部食品藥物管理局刺激系統配合使用。此解決方案可相容於可充電和不可充電的 IPG（植入式脈衝產生器），並支援五種磁振造影相容型 IPG，從而為帕金森氏症和自發性震顫患者提供更廣泛的個人化深部腦部刺激治療。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球神經調控市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧與自主智慧
  • 生物技術、基因組學和精準醫學
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 植入式神經調控設備的應用日益普及
  • 非侵入性神經調控療法的應用日益增多
  • 智慧型可程式設計刺激器的整合正在推進
  • 將神經調控技術的應用範圍擴展到疼痛以外的領域。
  • 人們越來越關注個人化神經療法

第5章 終端用戶產業市場分析

• 醫院
• 專科診所
• 疼痛管理中心
• 神經科診所
• 居家醫療保健服務提供者

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球神經調控市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球神經調控市場規模、對比及成長率分析
• 全球神經調控市場表現：規模與成長，2020-2025年
• 全球神經調控市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 透過技術
• 體內神經調控，體外神經調控（非侵入性）
• 透過生物材料
• 聚合物生物材料、金屬生物材料、陶瓷生物材料
• 透過使用
• 慢性疼痛、尿失禁和糞便失禁、偏頭痛、脊椎手術後症候群、巴金森氏症、癲癇、震顫、憂鬱症
• 最終用戶
• 醫院、診所、居家醫療和其他應用
• 依類型細分：體內神經調控
• 植入式裝置，鞘內藥物傳輸系統
• 按類型細分：外部神經調控（非侵入性）
• 經顱磁刺激（TMS）、經顱直流電刺激（tDCS）、經皮神經電刺激（TENS）、周邊神經刺激（PNS）

第10章 區域與國家分析

• 全球神經調控市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球神經調控市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 神經調控市場：競爭格局及市場佔有率（2024年）
• 神經調控市場：公司估值矩陣
• 神經調控市場：公司概況
  • Abbott Laboratories
  • Soterix Medical Inc.
  • Boston Scientific Corporation
  • Medtronic plc
  • Synapse Biomedical Inc.

第37章：其他領先和創新企業

• Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics SA, Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年神經調控市場：提供新機會的國家
• 2030年神經調控市場：新興細分市場機會
• 2030年神經調控市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

Tariffs are impacting the neuromodulation market by increasing costs of imported electronic components, implantable biomaterials, microcontrollers, stimulation leads, and precision manufacturing equipment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-tech implants, while Asia-Pacific faces higher costs in device exports. These tariffs are increasing treatment costs and slowing adoption rates. However, they are also encouraging domestic production, localized component sourcing, and innovation in cost-efficient neuromodulation device designs.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including neuromodulation industry global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown rapidly in recent years. It will grow from $7.62 billion in 2025 to $8.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, growing incidence of neurological disorders, increased acceptance of minimally invasive therapies, expansion of specialized pain management centers, availability of advanced implantable devices.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $12.88 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted neuromodulation systems, rising demand for home-based neuromodulation therapies, expansion of indications in psychiatric and neurological disorders, growing focus on patient-specific stimulation protocols, continuous technological advancements in biomaterials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of non-invasive neuromodulation therapies, growing integration of smart and programmable stimulators, expansion of neuromodulation applications beyond pain, enhanced focus on personalized neurotherapy.

Increasing healthcare expenditures are projected to drive the growth of the neuromodulation market in the coming years. Healthcare expenditure encompasses the total funds allocated for health care and related activities, including health services provision, public and private health insurance, health research, and public health initiatives. Rising expenditures support the development and adoption of new therapies and diagnostic methods for neurological disorders, and they also provide additional funding for research into innovative neuromodulation technologies, enhancing their efficacy, safety, and targeting capabilities. For example, in June 2025, according to the Centers for Medicare & Medicaid Services, national health expenditures in 2023 increased by 7.5% to reach $4.9 trillion, or $14,570 per capita, representing 17.6% of the United States gross domestic product. Thus, the rising healthcare expenditure is fueling the growth of the neuromodulation market.

Leading players in the neuromodulation sector are prioritizing the development of next-generation solutions, including advanced implantable pulse generators (IPGs), to enhance therapeutic accuracy, improve patient comfort, and strengthen their competitive positioning. An IPG is a small, battery-powered device implanted beneath the skin commonly in the chest or abdominal area, that delivers controlled electrical stimulation to treat neurological disorders. Ongoing innovations focus on enabling greater personalization, extending battery life, and simplifying implantation procedures. For instance, in July 2023, Boston Scientific Corporation received approval from the U.S. Food and Drug Administration for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, intended for use with the fourth-generation Vercise Genus Deep Brain Stimulation system. The solution supports both rechargeable and non-rechargeable IPGs and accommodates five magnetic resonance-conditional implantable pulse generators, providing a broad range of options to personalize deep brain stimulation therapy for patients with Parkinson's disease or essential tremor.

In December 2024, electroCore Inc., a United States-based bioelectronic medicine company, completed the acquisition of NeuroMetrix Inc. for an undisclosed consideration. Through this transaction, electroCore seeks to strengthen its wearable neuromodulation offerings for chronic pain by incorporating NeuroMetrix's Quell(R) platform and broadening its portfolio of non-invasive bioelectronic therapies. NeuroMetrix Inc. specializes in the development of wearable neuromodulation solutions designed to address chronic pain management.

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuromodulation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuromodulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
• 2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
• 3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
• 4) By End-User: Hospitals; Clinics; Home Healthcare
• Subsegments:
• 1) By Internal Neuromodulation: Implantable Devices; Intrathecal Drug Delivery Systems
• 2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS); Transcranial Direct Current Stimulation (tDCS); Transcutaneous Electrical Nerve Stimulation (TENS); Peripheral Nerve Stimulation (PNS)
• Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.; Nevro Corp; NeuroPace Inc.; LivaNova PLC; NeuroSigma Inc.; Neuronetics Inc.; Bioness Inc.; Aleva Neurotherapeutics S.A.; Integer Holdings Corporation; Inspire Medical Systems Inc.; Saluda Medical Pty Ltd; Inbrain Neuroelectronics SAS; Pixium Vision SA; Neuromod Devices Limited; Cognito Therapeutics Inc.; PathMaker Neurosystems Inc.; Dignify Therapeutics Inc.; Neuros Medical Inc.; Koninklijke Philips N.V.; Omron Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Neuromodulation Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Neuromodulation Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Neuromodulation Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Neuromodulation Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence And Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics And Precision Medicine
  • 4.1.3 Industry 4.0 And Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Implantable Neuromodulation Devices
  • 4.2.2 Rising Use Of Non-Invasive Neuromodulation Therapies
  • 4.2.3 Growing Integration Of Smart And Programmable Stimulators
  • 4.2.4 Expansion Of Neuromodulation Applications Beyond Pain
  • 4.2.5 Enhanced Focus On Personalized Neurotherapy

5. Neuromodulation Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Pain Management Centers
• 5.4 Neurology Clinics
• 5.5 Home Healthcare Providers

6. Neuromodulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuromodulation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Neuromodulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Neuromodulation Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Neuromodulation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Neuromodulation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuromodulation Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuromodulation Market Segmentation

• 9.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Internal Neuromodulation, External Neuromodulation (Non-invasive)
• 9.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
• 9.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression
• 9.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Healthcare, Other Applications
• 9.5. Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Implantable Devices, Intrathecal Drug Delivery Systems
• 9.6. Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

10. Neuromodulation Market Regional And Country Analysis

• 10.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuromodulation Market

• 11.1. Asia-Pacific Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuromodulation Market

• 12.1. China Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuromodulation Market

• 13.1. India Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuromodulation Market

• 14.1. Japan Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuromodulation Market

• 15.1. Australia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuromodulation Market

• 16.1. Indonesia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuromodulation Market

• 17.1. South Korea Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuromodulation Market

• 18.1. Taiwan Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuromodulation Market

• 19.1. South East Asia Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuromodulation Market

• 20.1. Western Europe Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuromodulation Market

• 21.1. UK Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuromodulation Market

• 22.1. Germany Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuromodulation Market

• 23.1. France Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuromodulation Market

• 24.1. Italy Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuromodulation Market

• 25.1. Spain Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuromodulation Market

• 26.1. Eastern Europe Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuromodulation Market

• 27.1. Russia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuromodulation Market

• 28.1. North America Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuromodulation Market

• 29.1. USA Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuromodulation Market

• 30.1. Canada Neuromodulation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuromodulation Market

• 31.1. South America Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuromodulation Market

• 32.1. Brazil Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuromodulation Market

• 33.1. Middle East Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuromodulation Market

• 34.1. Africa Neuromodulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuromodulation Market Regulatory and Investment Landscape

36. Neuromodulation Market Competitive Landscape And Company Profiles

• 36.1. Neuromodulation Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Neuromodulation Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Neuromodulation Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Soterix Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Synapse Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neuromodulation Market Other Major And Innovative Companies

• Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc.

38. Global Neuromodulation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuromodulation Market

40. Neuromodulation Market High Potential Countries, Segments and Strategies

• 40.1 Neuromodulation Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Neuromodulation Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Neuromodulation Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer